Molecular modeling studies on the binding mode of the PD-1/PD-L1 complex inhibitors

Suliman Almahmoud, Haizhen A. Zhong

Research output: Contribution to journalArticle

Abstract

The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) is an immune checkpoint (ICP) overexpressed in various types of tumors; thus, it has been considered as an important target for cancer therapy. To determine important residues for ligand binding, we applied molecular docking studies to PD-1/PD-L1 complex inhibitors against the PD-L1 protein. Our data revealed that the residues Tyr56, Asp122, and Lys124 play critical roles in ligand binding to the PD-L1 protein and they could be used to design ligands that are active against the PD-1/PD-L1 complex. The formation of H-bonds with Arg125 of the PD-L1 protein may enhance the potency of the PD-1/PD-L1 binding.

Original languageEnglish (US)
Article number4654
JournalInternational journal of molecular sciences
Volume20
Issue number18
DOIs
StatePublished - Sep 2 2019

Fingerprint

CD274 Antigen
Molecular modeling
Programmed Cell Death 1 Receptor
apoptosis
Cell death
inhibitors
Ligands
ligands
proteins
Proteins
Tumors
Neoplasms
Chemical bonds

Keywords

  • Docking
  • Ligand-protein interactions
  • Protein-protein interactions
  • The PD-1/PD-L1 complex
  • The PD-L1 protein

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Molecular modeling studies on the binding mode of the PD-1/PD-L1 complex inhibitors. / Almahmoud, Suliman; Zhong, Haizhen A.

In: International journal of molecular sciences, Vol. 20, No. 18, 4654, 02.09.2019.

Research output: Contribution to journalArticle

@article{6bedff7e593346f1832c054cbaf80813,
title = "Molecular modeling studies on the binding mode of the PD-1/PD-L1 complex inhibitors",
abstract = "The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) is an immune checkpoint (ICP) overexpressed in various types of tumors; thus, it has been considered as an important target for cancer therapy. To determine important residues for ligand binding, we applied molecular docking studies to PD-1/PD-L1 complex inhibitors against the PD-L1 protein. Our data revealed that the residues Tyr56, Asp122, and Lys124 play critical roles in ligand binding to the PD-L1 protein and they could be used to design ligands that are active against the PD-1/PD-L1 complex. The formation of H-bonds with Arg125 of the PD-L1 protein may enhance the potency of the PD-1/PD-L1 binding.",
keywords = "Docking, Ligand-protein interactions, Protein-protein interactions, The PD-1/PD-L1 complex, The PD-L1 protein",
author = "Suliman Almahmoud and Zhong, {Haizhen A.}",
year = "2019",
month = "9",
day = "2",
doi = "10.3390/ijms20184654",
language = "English (US)",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "18",

}

TY - JOUR

T1 - Molecular modeling studies on the binding mode of the PD-1/PD-L1 complex inhibitors

AU - Almahmoud, Suliman

AU - Zhong, Haizhen A.

PY - 2019/9/2

Y1 - 2019/9/2

N2 - The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) is an immune checkpoint (ICP) overexpressed in various types of tumors; thus, it has been considered as an important target for cancer therapy. To determine important residues for ligand binding, we applied molecular docking studies to PD-1/PD-L1 complex inhibitors against the PD-L1 protein. Our data revealed that the residues Tyr56, Asp122, and Lys124 play critical roles in ligand binding to the PD-L1 protein and they could be used to design ligands that are active against the PD-1/PD-L1 complex. The formation of H-bonds with Arg125 of the PD-L1 protein may enhance the potency of the PD-1/PD-L1 binding.

AB - The programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) is an immune checkpoint (ICP) overexpressed in various types of tumors; thus, it has been considered as an important target for cancer therapy. To determine important residues for ligand binding, we applied molecular docking studies to PD-1/PD-L1 complex inhibitors against the PD-L1 protein. Our data revealed that the residues Tyr56, Asp122, and Lys124 play critical roles in ligand binding to the PD-L1 protein and they could be used to design ligands that are active against the PD-1/PD-L1 complex. The formation of H-bonds with Arg125 of the PD-L1 protein may enhance the potency of the PD-1/PD-L1 binding.

KW - Docking

KW - Ligand-protein interactions

KW - Protein-protein interactions

KW - The PD-1/PD-L1 complex

KW - The PD-L1 protein

UR - http://www.scopus.com/inward/record.url?scp=85072567704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072567704&partnerID=8YFLogxK

U2 - 10.3390/ijms20184654

DO - 10.3390/ijms20184654

M3 - Article

C2 - 31546905

AN - SCOPUS:85072567704

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 18

M1 - 4654

ER -